Lenalidomide can be safely combined with chlorambucil and rituximab in older patients with chronic lymphocytic leukemia

by Vitale, Candida, Ferrajoli, Alessandra
Published in Haematologica (2019)

Chronic Lymphocytic Leukemia

by Vaisitti, Tiziana, Arruga, Francesca, Ferrajoli, Alessandra
Published in Cancers (Basel) (2020)

Chronic Lymphocytic Leukemia: Treatment Options for Patients With Refractory Disease

by Motta, Marina, Wierda, William G., Ferrajoli, Alessandra
Published in Cancer (2009)

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia

by Khan, Maliha, Gibbons, Jamie L, Ferrajoli, Alessandra
Published in Onco Targets Ther (2017)

Invasive Fungal Infections in Acute Leukemia

by Bhatt, Vijaya R., Viola, George M., Ferrajoli, Alessandra
Published 2011

Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review

by Autore, Francesco, Strati, Paolo, Laurenti, Luca, Ferrajoli, Alessandra
Published in Haematologica (2018)

Ibrutinib-Associated Cardiovascular Events in a Patient Wearing an Implanted Loop Recorder

by Rivera, Daniel, Takahashi, Koichi, Durand, Jean-Bernard, Ferrajoli, Alessandra
Published in Mediterr J Hematol Infect Dis (2021)

The Role of Monoclonal Antibodies in the Management of Leukemia

by Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Published 2010

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia

by Falchi, Lorenzo, Baron, Jessica M., Orlikowski, Carrie Anne, Ferrajoli, Alessandra
Published in Mediterr J Hematol Infect Dis (2016)

Experience With Rituximab Immunotherapy as an Early Intervention in Patients With Rai Stage 0 to II Chronic Lymphocytic Leukemia

by Ferrajoli, Alessandra, Keating, Michael J., O’Brien, Susan, Cortes, Jorge, Thomas, Deborah A.
Published in Cancer (2011)

Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab

by Jain, Punit, Kanagal-Shamanna, Rashmi, Wierda, William, Ferrajoli, Alessandra, Keating, Michael, Jain, Nitin
Published in Hematol Oncol Stem Cell Ther (2016)

Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence

by Faderl, Stefan, Ferrajoli, Alessandra, Wierda, William, O'Brien, Susan, Lerner, Susan, Keating, Michael J.
Published in Cancer (2010)

Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

by Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
Published in Leuk Res (2009)

microRNA Therapeutics in Cancer — An Emerging Concept

by Shah, Maitri Y., Ferrajoli, Alessandra, Sood, Anil K, Lopez-Berestein, Gabriel, Calin, George A.
Published in EBioMedicine (2016)

A Phase 2 Study of Yttrium-90 Ibritumomab Tiuxetan (Zevalin) in Patients With Chronic Lymphocytic Leukemia

by Jain, Nitin, Wierda, William, Ferrajoli, Alessandra, Wong, Franklin, Lerner, Susan, Keating, Michael, O’Brien, Susan
Published in Cancer (2009)

Fludarabine, cyclophosphamide, and rituximab (FCR) plus GM-CSF as frontline treatment for patients with Chronic Lymphocytic Leukemia

by Strati, Paolo, Ferrajoli, Alessandra, Lerner, Susan, O’Brien, Susan, Wierda, William, Keating, Michael J, Faderl, Stefan
Published in Leuk Lymphoma (2013)

Second Cancers and Richter’s Transformation are the Leading Causes of Death in Patients with Trisomy 12 Chronic Lymphocytic Leukemia

by Strati, Paolo, Abruzzo, Lynne V., Wierda, William G., O’Brien, Susan, Ferrajoli, Alessandra, Keating, Michael J.
Published in Clin Lymphoma Myeloma Leuk (2015)

The Prognostic Difference of Monoallelic Versus Biallelic Deletion of 13q in Chronic Lymphocytic Leukemia

by Garg, Ravin, Wierda, William, Ferrajoli, Alessandra, Abruzzo, Lynne, Pierce, Sherry, Lerner, Susan, Keating, Michael, O’Brien, Susan
Published in Cancer (2011)

Myelosuppression After Frontline Fludarabine, Cyclophosphamide, and Rituximab in Patients With Chronic Lymphocytic Leukemia: Analysis of Persistent and New-Onset Cytopenia

by Strati, Paolo, Wierda, William, Burger, Jan, Ferrajoli, Alessandra, Tam, Constantine, Lerner, Susan, Keating, Michael J., O’Brien, Susan
Published in Cancer (2013)

Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic

by Terracciano, Daniela, Buonerba, Carlo, Scafuri, Luca, De Berardinis, Piergiuseppe, Calin, George A., Ferrajoli, Alessandra, Fabbri, Muller, Cimmino, Amelia
Published in Front Oncol (2020)